Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.115 USD | -3.04% | -9.76% | -10.48% |
May. 09 | Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.48% | 241M | |
+8.26% | 115B | |
+13.00% | 107B | |
-13.57% | 22.31B | |
-3.99% | 21.6B | |
-5.79% | 18.23B | |
-39.93% | 17.62B | |
+7.35% | 14.26B | |
+33.49% | 12.37B | |
-28.19% | 8.28B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- HC Wainwright Adjusts Price Target on Akebia Therapeutics to $2 From $1.25, Maintains Neutral Rating